CBMJ
Get informed when a big investor buys or sells
+ FollowOvervalued by 211.1% based on the discounted cash flow analysis.
| Market cap | $19,246.00 |
|---|---|
| Enterprise Value | $745,781.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.03 |
| Beta | 1.36 |
| Outstanding Shares | 54,491,028 |
| P/E Ratio | -1.19 |
|---|---|
| PEG | 1.2 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.6 |
| Enterprise Value to EBIT | -0.68 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.18 |
| Debt to Equity | 0.71 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data